Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014

Treating infections caused by carbapenemase-producing Enterobacteriaceae

(2014) L.S. Tzouvelekis et al.   CLINICAL MICROBIOLOGY AND INFECTION

Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014

(2014) M. Monaco et al.   Eurosurveillance

Control of carbapenemase-producing Klebsiella pneumoniae: a region-wide intervention

(2014) C Gagliotti et al.   Eurosurveillance

Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches

(2014) Ilias Karaiskos et al.   EXPERT OPINION ON PHARMACOTHERAPY

Colistin resistance in Klebsiella pneumoniae

(2014) Young-Mi Ah et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study

(2014) Abiola Olumuyiwa Olaitan et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae

(2014) L. Poirel et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In VivoEmergence of Colistin Resistance in Klebsiella pneumoniae Producing KPC-Type Carbapenemases Mediated by Insertional Inactivation of the PhoQ/PhoPmgrBRegulator

(2013) Antonio Cannatelli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae

(2013) L. Silvia Munoz-Price et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Rapid detection of blaVIM-1–37 and blaKPC1/2–12 alleles from clinical samples by multiplex PCR-based assays

(2013) Ilaria Frasson et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

(2013) L Silvia Munoz-Price et al.   LANCET INFECTIOUS DISEASES

Carbapenem-Sparing Antibiotic Regimens for Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit

(2012) F. Sbrana et al.   CLINICAL INFECTIOUS DISEASES

High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality

(2012) A. Capone et al.   CLINICAL MICROBIOLOGY AND INFECTION

Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: a case–control study

(2012) S. Shilo et al.   INFECTION

Working across the veterinary and human health sectors

(2012) L. Garcia-Alvarez et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Transposons and integrons in colistin-resistant clones of Klebsiella pneumoniae and Acinetobacter baumannii with epidemic or sporadic behaviour

(2012) Sonia M. Arduino et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae

(2011) Abraham Borer et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Colistin-Resistant, Klebsiella pneumoniae Carbapenemase (KPC)-Producing Klebsiella pneumoniae Belonging to the International Epidemic Clone ST258

(2011) T. Bogdanovich et al.   CLINICAL INFECTIOUS DISEASES

Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals

(2011) M.L. Mezzatesta et al.   CLINICAL MICROBIOLOGY AND INFECTION

Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients

(2011) F. Kontopidou et al.   CLINICAL MICROBIOLOGY AND INFECTION

Independent Emergence of Colistin-Resistant Enterobacteriaceae Clinical Isolates without Colistin Treatment : Table 1.

(2011) Shudan Chen et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Outbreak of Colistin-Resistant, Carbapenem-ResistantKlebsiella pneumoniaein Metropolitan Detroit, Michigan

(2010) Dror Marchaim et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination

(2010) F. Perez et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Risk Factors and Outcomes Associated with Acquisition of Colistin-Resistant KPC-Producing Klebsiella pneumoniae: a Matched Case-Control Study

(2010) O. Zarkotou et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae

(2009) Leanne B. Gasink et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK

(2009) M. Doumith et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Emergence in Italy of Klebsiella pneumoniae Sequence Type 258 Producing KPC-3 Carbapenemase

(2009) T. Giani et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae

(2008) A. Poudyal et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY